Position in TCRT
as of Dec 31, 2025
· filed Feb 12, 2026
Position Value
$969
+$246 QoQ
Shares Held
300
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TCRT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Dec 31, 2025CIBC Private Wealth Group LLC holds $101,906,850 across 130 Biotechnology names. TCRT ranks #100 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
200,425 | $79,699,001 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,087 | $3,212,962 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
15,684 | $2,864,525 | |
| 4 | LXRX |
Lexicon Pharmaceuticals, Inc.
|
1,950,000 | $2,242,500 | |
| 5 | ASND |
Ascendis Pharma A/S
|
9,382 | $2,000,617 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,943 | $1,499,743 | |
| 7 | PGEN |
Precigen, Inc.
|
274,712 | $1,148,296 | |
| 8 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
279,224 | $907,478 |
All Filings in TCRT
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $969 | 300 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $723 | 300 | Shares | Sole | 2025-11-24 | |
| 2025-06-30 | $1,455 | 300 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $441 | 300 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $573 | 300 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $966 | 300 | Shares | Sole | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||